Health

Takeda Announces U.S. FDA Approval of Gammagard Liquid ERC, the Only Ready-to-Use Liquid Immunoglobulin Therapy with Low Immunoglobulin A (IgA) Content

DailyTrendDailyTrend
Jul 2, 2025 - 11:00
 0  0
Takeda Announces U.S. FDA Approval of Gammagard Liquid ERC, the Only Ready-to-Use Liquid Immunoglobulin Therapy with Low Immunoglobulin A (IgA) Content
OSAKA, Japan and CAMBRIDGE, Massachusetts, June 30, 2025 – Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved Gammagard Liquid ERC [immune globulin infusion (human)] with less than or equal...
Read More

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Angry Angry 0
Sad Sad 0
Wow Wow 0
DailyTrend
DailyTrend

Related Posts

Anne Merriman, ‘Mother of Palliative Care’ in Uganda, D...

DailyTrend Jul 2, 2025  0  0

FDA Grants Accelerated Approval to Lynozyfic (linvoseltamab-gcpt) for Treatment of Relapsed or Refractory Multiple Myeloma

FDA Grants Accelerated Approval to Lynozyfic (linvoselt...

DailyTrend Jul 3, 2025  0  0

Federal Judge Halts RFK Jr.’s Mass Firing Efforts at H.H.S. For Now

Federal Judge Halts RFK Jr.’s Mass Firing Efforts at H....

DailyTrend Jul 2, 2025  0  0

Maybe It’s Not Just Aging. Maybe It’s Anemia.

Maybe It’s Not Just Aging. Maybe It’s Anemia.

DailyTrend Jun 29, 2025  0  0

A Common Assumption About Aging May Be Wrong, Study Suggests

A Common Assumption About Aging May Be Wrong, Study Sug...

DailyTrend Jul 1, 2025  0  0

Drugmakers Notch a $5 Billion Win in Republicans’ Policy Bill

Drugmakers Notch a $5 Billion Win in Republicans’ Polic...

DailyTrend Jul 4, 2025  0  0